Clinical TrialsSearch results
Number of results: 193
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Completed
- Efficiency of transcranial direct current electrical stimulation for voice disorder
- Voice disorder(Spasmodic dysphonia,essential Voice tremor, Psychogenic dysphonia)
- Kiyuna Asanori
- 2019-03-29
Completed
- Multi-institutional retrospective observational study of definitive radiotherapy/chemoradiotherapy in cervical cancer
- Uterine cervical cancer
- Toita Takafumi
- 2021-09-30
Other
- Efficacy and Safety of Zoledronic acid on urological cancer patients with bone metastasis: a phase II clinical study.
- Urological Cancer with bone metastasis (Hormone resistant prostate cancer, Kidney cancer, urothelial cancer, kidney pelvis and ureteral cancer)
- Department of Urology, Graduate School of Medical Sciences, Kyushu University
- 2009-08-10
Other
- Hypertension Objective Treatment Based on Measurement by Electrical Devices of Blood Pressure (HOMED-BP) Study: Prospective Randomized Open-label Blinded Endpoint (PROBE)
- Untreated essential hypertensive patients
- HOMED-BP Study Group
- 2005-09-09
Other
- Rituximab + standard CHOP (R S-CHOP) vs Rituximab + bi-weekly CHOP (R Bi-CHOP) RCT(phase II/III) low-grade B-cell lymphoma at advanced stage (LowBNHL-RS/BiCHOP-P2/3) (JCOG0203)
- Untreated CD20-positive low-grade B-cell lymphoma at advanced stage
- Japan Clinical Oncology Group(JCOG)
- 2005-07-30
Other
- Unruptured Cerebral Aneurysm Study in Japan
- Unruptured intracranial aneurysms
- Society of Japan Neurosurgical Society
- 2006-05-17
Other
- A phase I/II study of percutaneous radiofrequency ablation for malignant lung tumor (JIVROSG-0203)
- Unresectable malignant lung tumor.
- Japan Interventional Radiology in Oncology Study Group (JIVROSG)
- 2005-08-06
Other
- Phase II study of combination therapy with Irinotecan and S-1 in patients with progressive colorectal cancer after FOLFOX regimen
- Unresectable advanced/recurrent colorectal cancer
- KSCC
- 2008-08-29
Other
- Safety and efficacy of Alternating mFOLFOX6 and FOLFIRI every 4cycles as First line Therapy in Advanced colorectal Cancer
- Unresectable advanced/recurrent colorectal cancer
- KSCC
- 2008-08-29
Other
- Safety and efficacy of Alternating mFOLFOX6 plus bevacizumab and FOLFIRI plus bevacizumab every 4cycles as First line Therapy in Advanced colorectal Cancer
- Unresectable advanced/recurrent colorectal cancer
- KSCC
- 2008-08-12